Department of Surgery, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
Department of Anaesthesia, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria.
Niger Postgrad Med J. 2020 Oct-Dec;27(4):302-310. doi: 10.4103/npmj.npmj_242_20.
This study aimed at evaluating the endoscopic management and clinical outcomes in patients with obstructive jaundice undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) within a newly established apprenticeship teaching model at an academic centre in a resource-limited setting.
We employed an apprenticeship-style model of ERCP training with graded responsibility, multidisciplinary group feedback and short-interval repetition. We collected sociodemographic and clinicopathologic data on consecutive patients who underwent ERCP from March 2018 to February 2020.
A total of 177 patients were referred, of which 146 patients had an ERCP performed for obstructive jaundice and 31 excluded during the study period. The median age was 55 years, age range from 8 to 83 years. The most common referral diagnosis was pancreatic head cancer 56/146 (38.1%), followed by choledocholithiasis 29/146 (19.7%), cholangiocarcinoma 22/146 (15.0%) and gall bladder cancer 11/146 (7.5%). In all, 102 patients had a malignant indication for ERCP. The cannulation rate was 92%. The most common site for malignant biliary obstruction was proximal bile stricture in 31/102 (30.4%), followed by distal bile strictures in 30/102 (28.4%), periampullary cancer 20/102 (19.6%) and mid bile duct stricture in 9/102 (8.8%). The common benign obstructive etiology includes choledocholithiasis in 33/44 (75%) and mid duct obstruction from post-cholecystectomy bile duct injury in 3/44 (2.9%) while 2/44 (2.0%) patients had choledochal cyst. Overall complications were post-ERCP pancreatitis (8/146 patients), cholangitis (3/146 patients), stent migration and post-sphincterotomy bleeding (one patient each). Peri-procedural mortality was 5/146 (3.4%).
ERCP is an effective and safe method of treatment of patients with benign and malignant biliary obstruction. The low morbidity and mortality and its immediate therapeutic benefits, together with the short duration of hospitalization, indicate that this procedure is an important asset in the management of such patients.
本研究旨在评估在资源有限环境下的学术中心中,采用新建立的学徒式教学模式进行内镜逆行胰胆管造影术(ERCP)的患者的内镜治疗管理和临床结局。
我们采用 ERCP 培训的学徒式模式,实行分级责任、多学科小组反馈和短间隔重复。我们收集了 2018 年 3 月至 2020 年 2 月连续接受 ERCP 治疗的患者的社会人口学和临床病理数据。
共转介了 177 例患者,其中 146 例因阻塞性黄疸行 ERCP 治疗,31 例在研究期间被排除。中位年龄为 55 岁,年龄范围为 8-83 岁。最常见的转介诊断为胰头癌 56/146(38.1%),其次为胆总管结石 29/146(19.7%)、胆管癌 22/146(15.0%)和胆囊癌 11/146(7.5%)。共有 102 例患者因恶性疾病行 ERCP 治疗。插管成功率为 92%。恶性胆道梗阻的最常见部位为近端胆管狭窄 31/102(30.4%),其次为远端胆管狭窄 30/102(28.4%)、壶腹周围癌 20/102(19.6%)和中胆管狭窄 9/102(8.8%)。常见的良性梗阻病因包括胆总管结石 33/44(75%)和胆囊切除术后胆管损伤引起的中胆管梗阻 3/44(2.9%),而 2/44(2.0%)患者为胆总管囊肿。总体并发症包括 ERCP 后胰腺炎(146 例患者中的 8 例)、胆管炎(146 例患者中的 3 例)、支架移位和括约肌切开后出血(各 1 例)。围手术期死亡率为 5/146(3.4%)。
ERCP 是治疗良性和恶性胆道梗阻患者的有效且安全的方法。低发病率和死亡率以及其即刻治疗益处,加上住院时间短,表明该手术是此类患者治疗的重要手段。